Cargando…
Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation
Use of antioxidants to mitigate oxidative stress during ocular inflammatory diseases has shown therapeutic potential. This work examines a nanoscale therapeutic modality for the eye on the base of antioxidant enzyme, superoxide dismutase 1 (SOD1), termed “nanozyme.” The nanozyme is produced by elect...
Autores principales: | Kost, Olga A., Beznos, Olga V., Davydova, Nina G., Manickam, Devika S., Nikolskaya, Irina I., Guller, Anna E., Binevski, Petr V., Chesnokova, Natalia B., Shekhter, Anatoly B., Klyachko, Natalia L., Kabanov, Alexander V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678082/ https://www.ncbi.nlm.nih.gov/pubmed/26697135 http://dx.doi.org/10.1155/2016/5194239 |
Ejemplares similares
-
Superoxide Dismutase 1 Nanoparticles (Nano-SOD1) as a Potential Drug for the Treatment of Inflammatory Eye Diseases
por: Vaneev, Alexander N., et al.
Publicado: (2021) -
Chitosan-Covered Calcium Phosphate Particles Co-Loaded with Superoxide Dismutase 1 and ACE Inhibitor: Development, Characterization and Effect on Intraocular Pressure
por: Popova, Ekaterina, et al.
Publicado: (2023) -
Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye
por: Vaneev, Alexander, et al.
Publicado: (2021) -
Deciphering the catalytic mechanism of superoxide dismutase activity of carbon dot nanozyme
por: Gao, Wenhui, et al.
Publicado: (2023) -
A Direct Comparison of Peptide Drug Delivery Systems Based on the Use of Hybrid Calcium Phosphate/Chitosan Nanoparticles versus Unmixed Calcium Phosphate or Chitosan Nanoparticles In Vitro and In Vivo
por: Popova, Ekaterina, et al.
Publicado: (2023)